Drawing for RUVEMBRI

USPTO serial 79397386

RUVEMBRI

Reviewed by CopyMark Law Group

Reg. 7813467Status 700Registered
Filing date
Status date
Registration date
Jun 3, 2025
Examiner
ADORNO SANTOS, LUZ M.
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RUVEMBRI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Molly Hunsinger

Molly Hunsinger Ladas & Parry LLP224 S. Michigan Ave., Ste. 1600Chicago, IL 60604United States

Goods and services

ClassDescriptionStatusFirst use
005Prescription medicine and over-the-counter pharmaceutical products for the treatment of neuromuscular diseases; sanitary products for medicine, namely, sanitary preparations for medical purposes; chemical preparations for medical or pharmaceutical use for the treatment of neuromuscular diseases; food for babies; medical plasters, material for dressings, namely, sterile gauze dressing pads; materials for dental fillings and for making dental impressions; disinfectants; vitamins, vitamin-based preparations, dietetic substances for medical use, namely, dietetic preparations adapted for medical purposes; natural dietetic foods and remedy preparations based on medicinal plants adapted for medical or veterinary use for the treatment of neuromuscular diseases; dietetic beverages and foodstuffs adapted for medicinal use; food supplements and nutritional food additives for medicinal use in the nature of natural food extracts derived from fish, meat, vegetables, plants and herbs ; mineral food supplements for medicinal use; nutritional supplements, plant-based preparations in the nature of plant extracts, other than essential oils, for medicinal use; food supplements containing proteins, carbohydrates, lipids and/or fibers, or micronutrients such as vitamins and/or minerals, amino acids and/or fatty acids, for medical use; medicinal herbal extracts, other than essential oils, for medicinal purposes; preparations for making dietetic and medicated beverages, namely, syrups for making meal replacement beverages adapted for medical use, vitamin supplement in tablet form for use in making an effervescent beverage when added to water; medicinal preparations for the treatment of neuromuscular diseases; chemical preparations for medicinal use for the treatment of neuromuscular diseases; medicated candy and confectionery for medicinal use; pharmacological preparations for skin careACTIVE—
042Scientific and technological services, namely chemical research, biological research and pharmaceutical research; research and development of new products for others; design and development of software and databases in the field of health; clinical studies, namely, scientific study services in the field of medicine, the prevention, treatment and management of neuromuscular diseases; scientific information services by providing scientific data in the field of pharmaceuticals; research in the field of pharmaceutical products; biological, clinical and medical research in the field of neuromuscular diseases; biotechnological research; scientific research for medical purposes in the field of neuromuscular diseases; computer-aided scientific research services in the field of neuromuscular diseases; information service concerning scientific research; preparation of reports concerning scientific research; advice relating to research and development in the therapeutic pharmaceuticals field; providing information and data with respect to medical and veterinary research and product development; conversion of computer programs and data, other than physical conversion; conversion of documents from a physical medium to an electronic mediumACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 22, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 3, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 3, 2026FIMPFINAL DISPOSITION PROCESSED—
Nov 30, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Nov 22, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 12, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 12, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 3, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 3, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 3, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 15, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 15, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 9, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 17, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 19, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 19, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 19, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 26, 2024RFNTREFUSAL PROCESSED BY IB—
Oct 10, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 10, 2024RFRRREFUSAL PROCESSED BY MPU—
Oct 8, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 7, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 2, 2024DOCKASSIGNED TO EXAMINER—
Jun 18, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 18, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 13, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance